Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
QuantShares U.S. Market Neutral Momentum Fund
(NY:
MOM
)
23.52
USD
UNCHANGED
Streaming Delayed Price
/ Updated:
6:40 PM EDT, Jun 13, 2013
/
Add to My Watchlist
View:
Quote
Overview
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Fund Overview
QuantShares U.S. Market Neutral Momentum Fund
Sector
Exchange Traded
NY
Net Assets
1.18M
Inception Date
Related Funds
122847
SSAM
FSA
QXM-A
Quote
Price
23.52
Volume
0
Last Trade
Jun 13, 6:40pm
Change (%)
+0.00 (0.00%)
Prev. Close
23.52
YTD %
-3.69%
Dividend Yield
N/A
Performance
YTD
-0.90 (-3.69%)
1 Month
-0.28 (-1.18%)
3 Month
-0.78 (-3.21%)
6 Month
-1.20 (-4.85%)
1 Year
-2.35 (-9.08%)
Chart
Charting
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Miraculins Announces Grant of Options
June 04, 2013
from
Marketwired
Miraculins Reports First Quarter Financial Results for Fiscal 2013
April 26, 2013
from
Marketwired
Top News
More News
Miraculins Executes Term Sheet to Acquire the SCOUT DS(R) Non-Invasive Diabetes Screening Technology
April 15, 2013
from
Marketwired
Miraculins Announces Closing of Private Placement Offering
April 08, 2013
from
Marketwired
Miraculins Announces Private Placement Offering
March 25, 2013
from
Marketwired
Miraculins Announces National Accreditation of Pharmacist Education Program on Cardiovascular Risk Assessment with Focus on Skin Cholesterol
March 15, 2013
from
Marketwired
Miraculins to License Additional Preeclampsia Technology from Mount Sinai Hospital
March 11, 2013
from
Marketwired
PreVu(R) Skin Cholesterol Clinics Rollout Nationally
February 27, 2013
from
Marketwired
Miraculins Moves Closer to PreVu(R) Expansion in U.S. and UK/EU through Key Market Development Team Appointments
February 19, 2013
from
Marketwired
Miraculins Initiates Pilot Study to Measure Skin Cholesterol Levels in Patients Beginning Statin Therapy
February 12, 2013
from
Marketwired
Miraculins Named Manitoba Life Science Company of the Year
February 04, 2013
from
Marketwired
Miraculins Updates Market on 2013 Plans for PreVu(R)
January 28, 2013
from
Marketwired
Alere Executes License Agreement with Miraculins for Preeclampsia Technology
January 10, 2013
from
Marketwired
Miraculins Announces PreVu(R) Test Expansion into Ontario and Atlantic Canada through PharmaChoice(R) Drug Stores
January 07, 2013
from
Marketwired
Miraculins Announces Expansion of PreVu(R) Testing to All London Drugs Pharmacies
December 20, 2012
from
Marketwired
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here